Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
EMBO Rep. 2020 Jan 7;21(1):e48741. doi: 10.15252/embr.201948741. Epub 2019 Dec 2.
EMBO Rep. 2020.
PMID: 31788936
Free PMC article.
Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer.
Kietzman WB, Graham GT, Ory V, Sharif GM, Kushner MH, Gallanis GT, Kallakury B, Wellstein A, Riegel AT.
Kietzman WB, et al.
Mol Cancer Ther. 2019 Dec;18(12):2220-2232. doi: 10.1158/1535-7163.MCT-19-0231. Epub 2019 Aug 26.
Mol Cancer Ther. 2019.
PMID: 31451564
Free PMC article.
Item in Clipboard
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer.
Sharif GM, Campbell MJ, Nasir A, Sengupta S, Graham GT, Kushner MH, Kietzman WB, Schmidt MO, Pearson GW, Loudig O, Fineberg S, Wellstein A, Riegel AT.
Sharif GM, et al.
Cancer Res. 2021 Aug 15;81(16):4230-4241. doi: 10.1158/0008-5472.CAN-20-3625. Epub 2021 Jun 16.
Cancer Res. 2021.
PMID: 34135000
Free PMC article.
Item in Clipboard
Cite
Cite